News
Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...
Neel Shah, MD, our first 2025 Oncology Icon, reflected on his journey from academic medicine to community oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback